Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis A Moretta, C Bottino, M Vitale, D Pende, C Cantoni, MC Mingari, ... Annual review of immunology 19 (1), 197-223, 2001 | 2185 | 2001 |
Receptors for HLA class-I molecules in human natural killer cells A Moretta, C Bottino, M Vitale, D Pende, R Biassoni, MC Mingari, ... Annual review of immunology 14 (1), 619-648, 1996 | 1059 | 1996 |
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule C Bottino, R Castriconi, D Pende, P Rivera, M Nanni, B Carnemolla, ... The Journal of experimental medicine 198 (4), 557-567, 2003 | 1055 | 2003 |
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non–major histocompatibility complex–restricted tumor cell lysis M Vitale, C Bottino, S Sivori, L Sanseverino, R Castriconi, E Marcenaro, ... The Journal of experimental medicine 187 (12), 2065-2072, 1998 | 963 | 1998 |
Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor H Ikeda, B Lethé, F Lehmann, N Van Baren, JF Baurain, C De Smet, ... Immunity 6 (2), 199-208, 1997 | 919 | 1997 |
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells R Castriconi, C Cantoni, M Della Chiesa, M Vitale, E Marcenaro, R Conte, ... Proceedings of the National Academy of Sciences 100 (7), 4120-4125, 2003 | 810 | 2003 |
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains N Wagtmann, R Biassoni, C Cantoni, S Verdiani, MS Malnati, M Vitale, ... Immunity 2 (5), 439-449, 1995 | 709 | 1995 |
p46, a novel natural killer cell–specific surface molecule that mediates cell activation S Sivori, M Vitale, L Morelli, L Sanseverino, R Augugliaro, C Bottino, ... The Journal of experimental medicine 186 (7), 1129-1136, 1997 | 704 | 1997 |
P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of … A Moretta, M Vitale, C Bottino, AM Orengo, L Morelli, R Augugliaro, ... The Journal of experimental medicine 178 (2), 597-604, 1993 | 630 | 1993 |
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells S Sivori, M Falco, MD Chiesa, S Carlomagno, M Vitale, L Moretta, ... Proceedings of the National Academy of Sciences 101 (27), 10116-10121, 2004 | 584 | 2004 |
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily C Cantoni, C Bottino, M Vitale, A Pessino, R Augugliaro, A Malaspina, ... The Journal of experimental medicine 189 (5), 787-796, 1999 | 568 | 1999 |
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. A Moretta, S Sivori, M Vitale, D Pende, L Morelli, R Augugliaro, C Bottino, ... The Journal of experimental medicine 182 (3), 875-884, 1995 | 547 | 1995 |
NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor M Vitale, MD Chiesa, S Carlomagno, D Pende, M Arico, L Moretta, ... Blood 106 (2), 566-571, 2005 | 485 | 2005 |
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin D Pende, C Cantoni, P Rivera, M Vitale, R Castriconi, S Marcenaro, ... European journal of immunology 31 (4), 1076-1086, 2001 | 455 | 2001 |
Effect of tumor cells and tumor microenvironment on NK‐cell function M Vitale, C Cantoni, G Pietra, MC Mingari, L Moretta European journal of immunology 44 (6), 1582-1592, 2014 | 434 | 2014 |
The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function MD Chiesa, S Carlomagno, G Frumento, M Balsamo, C Cantoni, R Conte, ... Blood 108 (13), 4118-4125, 2006 | 424 | 2006 |
Human natural killer cell receptors and co‐receptors R Biassoni, C Cantoni, D Pende, S Sivori, S Parolini, M Vitale, C Bottino, ... Immunological reviews 181 (1), 203-214, 2001 | 409 | 2001 |
Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes A Moretta, R Biassoni, C Bottino, D Pende, M Vitale, A Poggi, MC Mingari, ... Immunological reviews 155 (1), 105-117, 1997 | 396 | 1997 |
Effector and regulatory events during natural killer–dendritic cell interactions L Moretta, G Ferlazzo, C Bottino, M Vitale, D Pende, MC Mingari, ... Immunological reviews 214 (1), 219-228, 2006 | 384 | 2006 |
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity G Pietra, C Manzini, S Rivara, M Vitale, C Cantoni, A Petretto, M Balsamo, ... Cancer research 72 (6), 1407-1415, 2012 | 370 | 2012 |